← All American Oncology Network, INC filings

American Oncology Network, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
AONC
American Oncology Network, INC
10-K: American Oncology Network Delists from Nasdaq, Reports Growth in 2024
American Oncology Network voluntarily delisted from Nasdaq, transitioned to OTCQX, and reported revenue growth driven by increased patient encounters and strategic initiatives in its 2024 10-K filing.
OTC.Pink
AONC
American Oncology Network, INC
10-K/A: American Oncology Network Files Amended 10-K Report, Addressing Proxy Statement Delay and Including Updated Certifications
American Oncology Network has filed an amendment to its annual report on Form 10-K to include required information and updated certifications due to a delay in filing its definitive proxy statement.
OTC.Pink
AONC
American Oncology Network, INC
10-K: AON Outlines Capital Structure and Shareholder Rights in SEC Filing
American Oncology Network details its authorized capital stock, voting rights, dividend policies, and liquidation preferences in a recent SEC filing.